Literature DB >> 25126770

Malignant melanoma of the lacrimal drainage apparatus complicating conjunctival melanoma.

Khami Satchi1, Penny McKelvie, Alan A McNab.   

Abstract

PURPOSE: Melanoma of the conjunctiva may occasionally involve the lacrimal drainage apparatus (LDA). This makes clinical management difficult. The authors describe 5 cases of conjunctival melanoma with LDA disease and make recommendations about its management.
METHODS: Retrospective review of case notes and histopathology reports.
RESULTS: Five cases of LDA melanoma arising in patients with conjunctival melanoma are described. All 5 had orbital exenteration as part of their treatment. Melanoma of the LDA was clinically present at the time of exenteration in 1 case, found unexpectedly in 2 cases, and developed subsequent to exenteration in 2 cases. One patient died within 8 months of exenteration from metastatic melanoma. Two patients were disease free 3 and 5 years after exenteration. One patient developed metastasis in the parotid gland 4 years after exenteration but remained disease free 7 years after exenteration. One more patient has had a local recurrence in the maxilla and lateral nasal wall 4 years after exenteration, and after resection of that lesion and radiotherapy is disease free after 18 months. Seventeen patients underwent orbital exenteration for conjunctival melanoma over the period 1996-2013 at the authors'institution, with 5 having or developing LDA disease (29%). In the same period, there were 52 patients with conjunctival melanoma overall, with LDA involvement occurring in 5 of 52 patients (9.6%).
CONCLUSIONS: Melanoma of the LDA may complicate conjunctival melanoma in a significant percentage of cases having orbital exenteration. The surgical technique for orbital exenteration in patients with conjunctival melanoma should take this into account by intentionally removing the lacrimal sac and upper nasolacrimal duct as well as the lacrimal canaliculi. If melanoma is found in the LDA, consideration should be given to wider en bloc excision of the LDA.

Entities:  

Mesh:

Year:  2015        PMID: 25126770     DOI: 10.1097/IOP.0000000000000256

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  5 in total

1.  Orbital mass as first presentation of metastatic p16-positive oropharyngeal squamous cell carcinoma.

Authors:  J Corbett; D Wilke; J Trites; N Lamond
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677

2.  Concurrent lacrimal gland melanocytoma and ocular melanocytosis in a dog.

Authors:  Ikki Mitsui; Seigi Nishimura
Journal:  J Vet Diagn Invest       Date:  2021-09-13       Impact factor: 1.569

Review 3.  [Adjuvant therapy and interdisciplinary follow-up care of conjunctival melanoma].

Authors:  L M Heindl; K R Koch; M Schlaak; C Mauch; C Cursiefen
Journal:  Ophthalmologe       Date:  2015-11       Impact factor: 1.059

4.  m6A modification suppresses ocular melanoma through modulating HINT2 mRNA translation.

Authors:  Ruobing Jia; Peiwei Chai; Shanzheng Wang; Baofa Sun; Yangfan Xu; Ying Yang; Shengfang Ge; Renbing Jia; Yun-Gui Yang; Xianqun Fan
Journal:  Mol Cancer       Date:  2019-11-14       Impact factor: 27.401

5.  Melanorrhea: Noncontiguous spread of palpebral conjunctival melanoma to the nasolacrimal duct.

Authors:  Raksha Rao; Santosh G Honavar; Michelle De Padua; Kaustubh Mulay; Vijayanand P Reddy
Journal:  Indian J Ophthalmol       Date:  2018-02       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.